Vanda Pharma Insider Moves: Owner Sells 30k Shares Amid Exec Buying Surge
Vanda Pharmaceuticals insider activity: a modest 30k‑share sell by owner Honore Tage amid a massive 850k‑share buying spree by executives, suggesting portfolio rebalancing, not a downturn, while investors eye clinical milestones and funding news for…
3 minutes to read
